DK3898638T3 - Krystallinske former af en par4-hæmmer - Google Patents
Krystallinske former af en par4-hæmmer Download PDFInfo
- Publication number
- DK3898638T3 DK3898638T3 DK19842497.0T DK19842497T DK3898638T3 DK 3898638 T3 DK3898638 T3 DK 3898638T3 DK 19842497 T DK19842497 T DK 19842497T DK 3898638 T3 DK3898638 T3 DK 3898638T3
- Authority
- DK
- Denmark
- Prior art keywords
- crystalline forms
- par4 inhibitor
- par4
- inhibitor
- crystalline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
- C07C55/10—Succinic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/265—Citric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862783223P | 2018-12-21 | 2018-12-21 | |
| PCT/US2019/067717 WO2020132381A1 (en) | 2018-12-21 | 2019-12-20 | Crystalline forms of a par4 inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3898638T3 true DK3898638T3 (da) | 2023-11-20 |
Family
ID=69187955
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK19842497.0T DK3898638T3 (da) | 2018-12-21 | 2019-12-20 | Krystallinske former af en par4-hæmmer |
Country Status (30)
| Country | Link |
|---|---|
| US (2) | US12129264B2 (da) |
| EP (1) | EP3898638B1 (da) |
| JP (1) | JP7473554B2 (da) |
| KR (1) | KR20210109559A (da) |
| CN (3) | CN121021534A (da) |
| AU (2) | AU2019403348B2 (da) |
| BR (1) | BR112021011688A2 (da) |
| CA (1) | CA3124100A1 (da) |
| CL (1) | CL2021001590A1 (da) |
| CO (1) | CO2021008043A2 (da) |
| DK (1) | DK3898638T3 (da) |
| EA (1) | EA202191760A1 (da) |
| ES (1) | ES2964404T3 (da) |
| FI (1) | FI3898638T3 (da) |
| HR (1) | HRP20231527T1 (da) |
| HU (1) | HUE064830T2 (da) |
| IL (2) | IL284222B2 (da) |
| LT (1) | LT3898638T (da) |
| MX (1) | MX2021007417A (da) |
| MY (1) | MY206303A (da) |
| PE (1) | PE20211963A1 (da) |
| PL (1) | PL3898638T3 (da) |
| PT (1) | PT3898638T (da) |
| RS (1) | RS64900B1 (da) |
| SA (1) | SA521422311B1 (da) |
| SG (1) | SG11202106561RA (da) |
| SI (1) | SI3898638T1 (da) |
| SM (1) | SMT202300417T1 (da) |
| WO (1) | WO2020132381A1 (da) |
| ZA (1) | ZA202105115B (da) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT2841437T (lt) | 2012-04-26 | 2017-09-11 | Bristol-Myers Squibb Company | Imidazotiadiazolo ir imidazopirazino dariniai, kaip proteazės aktyvuotų receptorių 4 (par4) inhibitoriai, skirti trombocitų agregacijos gydymui |
-
2019
- 2019-12-20 PT PT198424970T patent/PT3898638T/pt unknown
- 2019-12-20 JP JP2021535787A patent/JP7473554B2/ja active Active
- 2019-12-20 US US17/415,237 patent/US12129264B2/en active Active
- 2019-12-20 RS RS20231120A patent/RS64900B1/sr unknown
- 2019-12-20 SM SM20230417T patent/SMT202300417T1/it unknown
- 2019-12-20 ES ES19842497T patent/ES2964404T3/es active Active
- 2019-12-20 CN CN202510888950.0A patent/CN121021534A/zh active Pending
- 2019-12-20 KR KR1020217022513A patent/KR20210109559A/ko active Pending
- 2019-12-20 LT LTEPPCT/US2019/067717T patent/LT3898638T/lt unknown
- 2019-12-20 EP EP19842497.0A patent/EP3898638B1/en active Active
- 2019-12-20 FI FIEP19842497.0T patent/FI3898638T3/fi active
- 2019-12-20 SG SG11202106561RA patent/SG11202106561RA/en unknown
- 2019-12-20 PL PL19842497.0T patent/PL3898638T3/pl unknown
- 2019-12-20 AU AU2019403348A patent/AU2019403348B2/en active Active
- 2019-12-20 CN CN201980085324.0A patent/CN113227102B/zh active Active
- 2019-12-20 IL IL284222A patent/IL284222B2/en unknown
- 2019-12-20 BR BR112021011688-5A patent/BR112021011688A2/pt unknown
- 2019-12-20 IL IL320212A patent/IL320212A/en unknown
- 2019-12-20 CA CA3124100A patent/CA3124100A1/en active Pending
- 2019-12-20 WO PCT/US2019/067717 patent/WO2020132381A1/en not_active Ceased
- 2019-12-20 SI SI201930650T patent/SI3898638T1/sl unknown
- 2019-12-20 MX MX2021007417A patent/MX2021007417A/es unknown
- 2019-12-20 PE PE2021000917A patent/PE20211963A1/es unknown
- 2019-12-20 EA EA202191760A patent/EA202191760A1/ru unknown
- 2019-12-20 DK DK19842497.0T patent/DK3898638T3/da active
- 2019-12-20 HU HUE19842497A patent/HUE064830T2/hu unknown
- 2019-12-20 HR HRP20231527TT patent/HRP20231527T1/hr unknown
- 2019-12-20 CN CN202510888947.9A patent/CN121021533A/zh active Pending
- 2019-12-20 MY MYPI2021003475A patent/MY206303A/en unknown
-
2021
- 2021-06-17 SA SA521422311A patent/SA521422311B1/ar unknown
- 2021-06-17 CL CL2021001590A patent/CL2021001590A1/es unknown
- 2021-06-18 CO CONC2021/0008043A patent/CO2021008043A2/es unknown
- 2021-07-20 ZA ZA2021/05115A patent/ZA202105115B/en unknown
-
2024
- 2024-10-08 US US18/908,888 patent/US20250026767A1/en active Pending
-
2025
- 2025-02-26 AU AU2025201372A patent/AU2025201372A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3810581T3 (da) | Krystalmodifikationer af odevixibat | |
| DK4045039T3 (da) | Hæmning af human integrin-alfa4beta7 | |
| IL284226A (en) | Novel polymorphic forms of a tgfb inhibitor | |
| IL286218A (en) | Solid state forms of ripretinib | |
| DK3972960T3 (da) | Krystallinske former af en btk-hæmmer | |
| EP4007756C0 (en) | KIF18A INHIBITORS | |
| HUE057852T2 (hu) | MCL-1 inhibítorok | |
| DK3472157T3 (da) | Krystallinske faste former af en bet-inhibitor | |
| IL277778B (en) | Bcl6 inhibitors | |
| DK3541807T3 (da) | Krystallinsk form af en magl-inhibitor | |
| DK3830085T3 (da) | Deutereret derivat af lanifibranor | |
| DK3894012T3 (da) | Krystallinske former og saltformer af en kinasehæmmer | |
| DK3759745T3 (da) | Dannelse af piezoelektriske anordninger | |
| DK3826982T3 (da) | Anvendelse af en substitueret thiazolidinforbindelse som nitrificeringshæmmer | |
| DK3844162T3 (da) | Hæmmere af alfa-v-beta6-integrin | |
| EP4003986A4 (en) | Inhibitor compounds | |
| DK3580197T3 (da) | Oprensning af pleuromutilin | |
| IL282454A (en) | Crystalline salts of a plasma kallikrein inhibitor | |
| EP3976797A4 (en) | ANTI-CRISPR INHIBITORS | |
| DK3826983T3 (da) | Anvendelse af substituerede 2-thiazoliner som nitrificeringshæmmere | |
| DK3749673T3 (da) | Krystallinsk form af bictegravir-natrium | |
| DK3630725T3 (da) | Krystallinsk form af n-butyldeoxygalactonojirimycin | |
| DK3847175T3 (da) | Krystallinske former af en phosphoinositid-3-kinase- (pi3k) inhibitor | |
| EP3812456A4 (en) | Growth inhibitor | |
| DK3713513T3 (da) | Fremgangsmåde til fremstilling af en protesedel |